THE AMERICAN BOARD OF VENOUS & LYM… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2007

Legal Domicile

Phone

4155616276

Tax Period

2024-01-01 to 2024-12-31

THE AMERICAN BOARD OF VENOUS & LYMPHATIC MEDICINE, founded in 2007, is a small nonprofit in the Community Improvement sector that reported $304K in total revenue in fiscal year 2024. Revenue fell 25% from the prior year — a significant decline worth monitoring. Expenses of $445K exceeded revenue, resulting in a 47% operating deficit.

Mission

IT IS THE MISSION OF THE AMERICAN BOARD OF VENOUS & LYMPHATIC MEDICINE TO IMPROVE THE QUALITY OF MEDICAL PRACTITIONERS AND THE CARE OF PATIENTS RELATED TO VENOUS AND LYMPHATIC DISORDERS THROUGH RIGOUROUS TESTING, RELIABLE CERTIFICATION, AND IMPROVED EDUCATIONAL STANDARDS.

Program Service Accomplishments

Program 1

DEVELOPMENT AND ADMINISTRATION OF A CERTIFICATION EXAMINATION FOR PHYSICIAN CANDIDATES SPECIALIZING IN THE PRACTICE OF VENOUS AND LYMPHATIC MEDICINE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $298,727

Investment Income $4,822

Other Revenue $0

TOTAL REVENUE $303,549

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Other Expenses $445,003

TOTAL EXPENSES $445,003

Year-over-Year Comparison

	2024	2023	Change
Revenue	$303,549	$402,213	-0.2%
Expenses	$445,003	$291,485	+0.5%
Net Income	$-141,454	$110,728	-2.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
NEIL KHILNANI	President	5.00	Officer Director	$0	$0	$0
Ronald Winokur	Director	1.00	Director	$0	$0	$0
John Fish	Treasurer	2.00	Officer Director	$0	$0	$0
Murad Alam	Director	1.00	Director	$0	$0	$0
Robert Attaran	Director	1.00	Director	$0	$0	$0
Carl Black	Director	1.00	Director	$0	$0	$0
Theresa Carman	Director	1.00	Director	$0	$0	$0
John Carson	Director	1.00	Director	$0	$0	$0
Mark Meissner	Vice President	2.00	Officer Director	$0	$0	$0
Omar Esponda	Director	1.00	Director	$0	$0	$0
Julianne Stoughton	Director	1.00	Director	$0	$0	$0
Carl Fastabend	Director	1.00	Director	$0	$0	$0
Fedor Lurie	Director	1.00	Director	$0	$0	$0
Vineet Mishra	Director	1.00	Director	$0	$0	$0
Lori Pounds	Director	1.00	Director	$0	$0	$0
Stanely Rockson	Director	1.00	Director	$0	$0	$0
Jeffery Schoonover	Director	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$303,549	$445,003	$590,508	$-141,454
2023	$402,213	$291,485	$784,531	$110,728
2022	$456,785	$260,537	$795,396	$196,248
2022	$139,081	$136,708	$665,244	$2,373
2021	$365,307	$264,156	$703,007	$101,151
2020	$258,851	$261,811	$657,486	$-2,960
2019	$393,419	$350,435	$619,025	$42,984
2018	$537,321	$653,217	$622,494	$-115,896

THE AMERICAN BOARD OF VENOUS & LYMPHATIC MEDICINE